C. Neutrophilic eccrine hidradenitis (NEH)
D. Urticarial drug eruption
E. Mycosis fungoides (MF)
Answers:
A. Sweet syndrome e Incorrect. Although Sweet syndrome is a neutrophilic dermatosis often associated with hematologic malignancies such as AML, it does not completely correlate with the involvement of the eccrine glands on histopathology.
B. DRESS e Incorrect. DRESS occurs 2 to 6 weeks after the administration of the offending agent and can resemble a morbilliform drug eruption, often involving greater than 50% body surface area. Leukocytosis with eosinophilia can be found on blood work. There is perivascular lymphocytic infiltrate on histology with eosinophils variably present.
C. NEH e Correct. NEH can occur in patients with malignancies such as AML in combination with certain chemotherapy agents, most commonly cytarabine. Erythematous and edematous plaques progress within 1 to 2 weeks of starting the offending agent and spontaneously resolve 1 to 2 weeks after cessation. [1] [2] [3] D. Urticarial drug eruption e Incorrect. This patient did not have the hallmark symptoms of rapid onset (due to the immunoglobulin Eemediated type I hypersensitivity), intensely pruritic plaques, or angioedema after administration of the offending agent.
E. MF e Incorrect. Although MF can present with a variety of morphologies, this morphology is not classic. It usually presents as scaly, thin, wrinkled patches in a bathing suit distribution. The histology also did not show any of the hallmark signs of MF such as Pautrier microabscesses, haloed lymphocytes, or hyperconvoluted intraepidermal lymphocytes. A. Discontinue cytarabine e Incorrect. Although NEH will resolve spontaneously within 1 to 2 weeks of stopping chemotherapy, there is no indication to stop treatment for AML. 1, 4 B. Start low-dose methotrexate e Incorrect. Methotrexate inhibits DNA synthesis by blocking the reduction of folate. Although methotrexate is useful in a variety of dermatologic diseases, its mechanism of action does not address the neutrophil-driven pathophysiology of NEH, nor has it ever been reported to be helpful in this condition.
C. Avoid piperacillin-tazobactam e Incorrect. This is unlikely to be a drug eruption because of the morphology of the eruption in this patient and the shorter time course between the administration of the antibiotic and the eruption than would be expected.
D. Start dapsone before chemotherapy e Correct. Dapsone is used in the treatment of many neutrophilic dermatoses because of its mechanism of action inhibiting myeloperoxidase and reducing the oxidant and free radical damage caused by neutrophils. There is descriptive evidence that dapsone can be used to suppress the outbreak of NEH in patients who require future chemotherapy cycles. However, the risks and benefits should be weighed before prescribing dapsone for a patient currently on chemotherapy because it can cause hemolysis and agranulocytosis. 4 E. Start an oral retinoid e Incorrect. Oral retinoids can be used for treatment of advanced MF and recalcitrant Sweet syndrome. There is no evidence for using oral retinoids for prophylaxis in chemotherapy-induced NEH. 
